2013

Stein, A., Kretzschmar, A., Behringer, D., Wolff, T., Zimber, J., Hegewisch-Becker, S., Kettner, E., Pfluger, K. H., Kirsch, A., Arnold, D. (2013).
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 Trial
BMC Cancer 13: 454.

2014

Behringer, D., Konemann, S.; Hecker, E. (2014)
Treatment approaches to primary tracheal cancer
Thorac Surg Clin 24(1): 73-76.

Dittrich, C., Papai-Szekely, Z.; Vinolas, N.; Sederholm, C.; Hartmann, J. T.; Behringer, D.; Kazeem, G.; Desaiah, D.; Leschinger, M. I.; von Pawel, J. (2014)
A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer
Eur J Cancer 50(9): 1571-1580

2015

Schue0tte, W., Behringer, D., Stoehlmacher, J., Kollmeier, J., Schmager, S., Fischer von Weikersthal, L., Schumann, C., Buchmann, J. (2015)
CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non-Small-Cell Lung Cancer With Particular Regard to the KRAS Status
Clin Lung Cancer 16(6): 447-456.

2016

Joerger, M., von Pawel, J.; Kraff, S.; Fischer, J. R.; Eberhardt, W.; Gauler, T. C.; Mueller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Mayer, F.; Kopp, H. G.; Behringer, D. M.; Ko, Y. D.; Hilger, R. A.; Roessler, M.; Kloft, C.; Henrich, A.; Moritz, B.; Miller, M. C.; Salamone, S. J.; Jaehde, U. (2016)
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Ann Oncol. 10.1093/annonc/mdw290